CA3293575A1 - Nouveau composé pour inhiber des protéines kinases et composition pharmaceutique le comprenant - Google Patents

Nouveau composé pour inhiber des protéines kinases et composition pharmaceutique le comprenant

Info

Publication number
CA3293575A1
CA3293575A1 CA3293575A CA3293575A CA3293575A1 CA 3293575 A1 CA3293575 A1 CA 3293575A1 CA 3293575 A CA3293575 A CA 3293575A CA 3293575 A CA3293575 A CA 3293575A CA 3293575 A1 CA3293575 A1 CA 3293575A1
Authority
CA
Canada
Prior art keywords
pharmaceutical composition
same
protein kinases
novel compound
inhibiting protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3293575A
Other languages
English (en)
Inventor
Tae Bo Sim
Ha Soon CHOI
In Jae Shin
Nam Kyoung Kim
Jung Yeol LEE
Sun You PARK
Myeong A CHOI
Ji Hoon Lee
Ye-Mi KWON
Sang Kyoon Kim
Da Yea KIM
Uk Yeol MOON
Original Assignee
Magicbullet Therapeutics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magicbullet Therapeutics Co Ltd filed Critical Magicbullet Therapeutics Co Ltd
Publication of CA3293575A1 publication Critical patent/CA3293575A1/fr
Pending legal-status Critical Current

Links

CA3293575A 2023-05-25 2024-05-24 Nouveau composé pour inhiber des protéines kinases et composition pharmaceutique le comprenant Pending CA3293575A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2023-0067836 2023-05-25
KR10-2024-0065022 2024-05-20

Publications (1)

Publication Number Publication Date
CA3293575A1 true CA3293575A1 (fr) 2026-03-01

Family

ID=

Similar Documents

Publication Publication Date Title
EP4134366A4 (fr) Dérivé de 3-azabicycloalkyle et composition pharmaceutique le contenant
AU2021416682A9 (en) 2-aminopyrimidine compound and pharmaceutical composition thereof and application thereof
EP4279486A4 (fr) Composé de 2-aminopyrimidine et composition pharmaceutique le comprenant et application associée
CA3263153A1 (fr) Inhibiteurs de kit, composés, compositions pharmaceutiques et leurs procédés d'utilisation
CA3293575A1 (fr) Nouveau composé pour inhiber des protéines kinases et composition pharmaceutique le comprenant
CA3261419A1 (fr) Composition pharmaceutique comprenant de la centanafadine
CA3301042A1 (fr) Composés pharmaceutiques et compositions en tant qu'inhibiteurs de kinase de c-kit
CA3292742A1 (en) Salt-inducible kinase inhibitor compound and pharmaceutical composition including the same
CA3282098A1 (fr) Nouveau composé et composition pharmaceutique le comprenant
CA3273332A1 (fr) Composition pharmaceutique comprenant un inhibiteur d'aak1
CA3275914A1 (fr) Composition pharmaceutique contenant du siponimod
CA3304158A1 (fr) Composition pharmaceutique de cabotégravir
CA3273940A1 (fr) Compositions pharmaceutiques contenant de la doravirine et de l'islatravir
CA3284165A1 (fr) Formulations comprenant des variants de protéine actriia
HK40110956A (en) Compounds for inhibiting or degrading target proteins, compositions, comprising the same, methods of their making, and methods of their use
CA3266746A1 (fr) Composé inhibiteur de kif18a, composition pharmaceutique et son procédé de préparation et son utilisation
HK40117767A (en) Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof
HK40094246A (en) Quinazoline compound and pharmaceutical composition thereof
AU2023901609A0 (en) Pharmaceutical composition
HK40128646A (zh) 抑制c3基因表达的化合物、药物组合物及其用途
CA3293688A1 (fr) Composé, composition pharmaceutique le comprenant et son utilisation
CA3293736A1 (fr) Nouveau composé dérivé de benzamide et composition pharmaceutique le comprenant
HK40119815A (en) Compound, pharmaceutical composition comprising same, and use thereof
CA3263919A1 (en) Compound, pharmaceutical composition comprising same, and use thereof
HK40131664A (en) Compounds and their uses as gpr183 inhibitors